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Introduction {#sec1}
============

In the later stages of human life, there is a sustained increase in innate immune activity that has been associated with aging ([@bib19]). This is in contrast to the induction of an immune response by infection and its rapid termination when the pathogen is cleared. This heightened age-associated pro-inflammatory activity has been termed "inflammageing" ([@bib19]). It is thought to be partly balancing the exhaustion of T cell-mediated immunity caused by a decrease in the number of naive T cells produced by the thymus because of organism-wide cell senescence ([@bib19], [@bib14]). Other causes include the accumulation of tissue damage during the removal of senescent cells in various tissues and a defective autophagy response ([@bib44]). One of the most important transcriptional signatures in inflammageing of both humans and mice is the activation of the pro-inflammatory nuclear factor κB (NF-κB) pathway ([@bib13], [@bib53]).

It has been hypothesized that, under certain conditions of heightened innate immunity, inflammageing may lead to age-associated brain neurodegeneration ([@bib21]). Although it is not known what predisposes individuals to disease, central to this immune-to-brain signaling are microglia. In the aging brain, the microglia have a primed phenotype as a consequence of changes in their local environment ([@bib37]). Nevertheless, whether the process involves the age-dependent activity of the NF-κB pathway is still an open question.

Taken together, the data mentioned above indicate the important influence of innate immunity on both healthy aging and age-related neurodegeneration. However, because cause and effect are so intricately linked (neurodegeneration itself causes inflammation), it is unclear how common themes in signaling may end up with such distinct phenotypes (healthy aging versus neurological disease). In this context, we used *Drosophila* to explore the potential influence of NF-κB-controlled immune signaling in predisposition to age-related neurological disease as well as healthy aging.

In *Drosophila*, systemic infection triggers two NF-κB signaling pathways; namely, Toll and immune deficiency (IMD). The latter pathway has extensive similarities with the tumor necrosis factor receptor 1 (TNFR1) signaling cascade ([@bib28]). Upon infection, activation of IMD is triggered when fragments of peptidoglycan released by Gram-negative bacteria or Gram-positive bacilli bind the transmembrane peptidoglycan recognition protein (PGRP)-LC or the intracellular PGRP-LE ([@bib25]). The signal is then transduced through a receptor-adaptor complex to the NF-κB homolog Relish (Rel). Specifically, IMD (a RIP1 homolog) associates with the Fas-associated death domain protein (FADD), which then recruits the caspase-8 homolog death related ced-3/Nedd2-like caspase (DREDD), which is activated by ubiquitylation ([@bib35]). DREDD cleaves IMD, thus unmasking a domain of interaction with the *Drosophila* inhibitor of apoptosis-2 (dIAP-2), which ubiquitinates and stabilizes IMD ([@bib40]). This creates a transient signaling platform for the recruitment of transforming growth factor β (TGF-β)-activating kinase 1 (TAK1) and its binding adaptor TAB2 ([@bib18]). The TAK1/TAB2 complex mediates phosphorylation of the IκB kinase (IKK) on one hand and Jun nuclear kinase (JNK) on the other ([@bib46]). In turn, IKK phosphorylates the N-terminal domain of Rel, whereas DREDD cleaves the C-terminal. N-terminal Rel is then free to move to the nucleus and regulate transcriptional targets, including induction of antimicrobial peptide (AMP) genes ([@bib47]). As the signal is transmitted from the cell surface to the nucleus, there is negative regulation at every step. There is inhibition of PGRP-LC signaling by the transmembrane PGRP-LF ([@bib5]), inhibition of the receptor-adaptor complex through Rudra/Pirk ([@bib1]), and blocking of the signaling flow by successive de-ubiquitination enzymes targeting IMD (dUSP36) ([@bib48]), TAK1 (the A20 homolog Trabid) ([@bib18]), or IKK (the cylidromatosis disease homolog cylindromatosis \[CYLD\]) ([@bib49]). Moreover, ubiquitin-mediated proteolysis depletes the pathway from DREDD (via Dnr1) ([@bib22]), TAK1 (via plenty of SH3 \[POSH\]) ([@bib50]), and Relish (via ring and YY1 binding protein \[dRYBP\]) ([@bib4]), whereas transglutaminase (TG)-catalyzed protein-protein cross-linking prevents Relish from entering the nucleus ([@bib45]). Finally, Caspar inhibits DREDD-dependent cleavage of Relish ([@bib27]). In addition, there are extracellular negative regulators represented by secreted catalytic PGRP proteins (PGRP-LB and PGRP-SC), which reduce the epithelial and/or systemic response by scavenging peptidoglycan ([@bib41]). The safeguarding of the IMD pathway at all levels and with multiple means underlines the notion of an important cost paid if these safeguards were to decrease or collapse. Indeed, lack of Trabid, Pirk, PGRP-SC, or PGRP-LB compromise lifespan ([@bib18], [@bib41]), whereas mutations in *dnr-1* or overexpression of AMPs in the brain result in neurodegeneration ([@bib9]). Similarly, continuous overexpression of PGRP-LE, leading to chronic upregulation of AMPs, compromised lifespan in a Relish-dependent manner, linking immunity, inflammation, and longevity in flies ([@bib31]). Moreover, TG has been associated with neurotoxicity in a spinocerebellar ataxia model ([@bib33]),whereas mutations in *relish* suppress neurodegeneration in an ataxia-telangiectasia model ([@bib42]). Nevertheless, innate immune genes are upregulated in fly models of neurodegeneration, raising the possibility that this upregulation may be protective ([@bib8]). In this context also, cause and consequence might be intimately linked.

In addition to the link between components of the immune system and neurodegeneration, there is an intimate connection between immunity and metabolism. In mammals, adipose tissues and infiltrating immune cells produce numerous bioactive factors that have pro-inflammatory or anti-inflammatory activities. Dysregulated production of so-called adipokines can contribute to the pathogenesis of obesity-linked metabolic disease (for a review, see [@bib39]). These players have been shown to drive type 2 diabetes, whereas cytokines regulate lipid stores (for a review, see [@bib17]). In flies, prolonged immune activation in the context of bacterial or viral infections has also been associated with deregulation of metabolism, mainly through the insulin signaling pathway ([@bib16]; [@bib15]). More recently, a switch between immunity and metabolism has been identified in the transcription factor Mef2. There, sustained immune activity removed Mef2 from metabolic regulation, whereas, in the absence of infection, Mef2 associated primarily with metabolic transcriptional signatures ([@bib12]).

The results presented here show that, with age, NF-κB-dependent AMP gene expression increased, and this was accompanied by progressive neurodegeneration and locomotion decline. Constitutive NF-κB immune signaling (in *pirk*, *trbd*, or *tg* mutants) resulted in high head and brain AMPs. Flies had a short lifespan, severe neurodegeneration, and locomotor defects. Conversely, reducing the normal levels of NF-κB in the brain of healthy flies resulted in an extended lifespan with improved activity in old age, accompanied by increased hormonal signaling and elevated glucose, trehalose, and triglycerides. Our results demonstrate that IMD/NF-κB/Relish immune signaling in glia determines lifespan.

Results {#sec2}
=======

Age-Dependent Immune Regulation in Flies {#sec2.1}
----------------------------------------

We monitored the age-related expression of negative regulators of IMD, Toll, and JNK by comparing healthy whole flies, heads, and the rest of the body in the absence of infection. Our results indicated a consistent pattern: age-dependent gene expression of IMD *intracellular* negative regulators was significantly reduced in heads ([Figure 1](#fig1){ref-type="fig"}A) compared with the rest of the body (where expression of some was increased, compare [Figure S1](#mmc1){ref-type="supplementary-material"}A with [Figure 1](#fig1){ref-type="fig"}A) or to whole flies (where expression appeared unchanged, compare [Figure S1](#mmc1){ref-type="supplementary-material"}B with [Figure 1](#fig1){ref-type="fig"}A). In contrast, expression of IMD *extracellular* negative regulators was increased with age in heads ([Figure 1](#fig1){ref-type="fig"}A), the rest of the body ([Figure S1](#mmc1){ref-type="supplementary-material"}A), and whole flies ([Figure S1](#mmc1){ref-type="supplementary-material"}B). The decrease of intracellular negative regulation in the heads of aging flies was paralleled by a dramatic increase in AMP gene expression in the heads of 30- and 50-day-old flies (compare [Figure 1](#fig1){ref-type="fig"}B with [Figures S1](#mmc1){ref-type="supplementary-material"}C and S1D for the rest of the body and whole flies respectively; see [Figure 1](#fig1){ref-type="fig"}C for a combined graph for a 30-day-old dataset; see [Figure S1](#mmc1){ref-type="supplementary-material"}E for a 50 day-old dataset). We also observed a statistically significant increase in expression levels of *rel* in heads and whole bodies of 30-day-old flies compared with young 5-day-old controls ([Figure S1](#mmc1){ref-type="supplementary-material"}F). *Dif* expression was also increased in the heads of 30-day-old flies ([Figure S1](#mmc1){ref-type="supplementary-material"}F). However, this increase was not to the same extent as *rel* (3.2-fold versus 1.9-fold induction for *rel* and *dif*, respectively; [Figure S1](#mmc1){ref-type="supplementary-material"}F). No significant change in expression of other components of the Toll or JNK pathway was observed with age ([Figure S1](#mmc1){ref-type="supplementary-material"}F).

Comparison of AMP gene expression levels in the heads of conventionally reared versus germ-free flies indicated the importance of the microbial environment in the age-dependent increase observed (compare [Figure 1](#fig1){ref-type="fig"}D with [Figure 1](#fig1){ref-type="fig"}C). The largest part of this increase (\>90%) was microbiota-dependent ([Figures S1](#mmc1){ref-type="supplementary-material"}G and S1H). Nevertheless, this still indicated that there was a microbially independent, intrinsic propensity for age-dependent deregulation of the IMD pathway ([Figures S1](#mmc1){ref-type="supplementary-material"}G and S1H). (Of note, that measurements under axenic conditions showed that the AMP gene expression increase concerned only IMD-regulated AMPs and not TOLL-dependent ones; [Figure 1](#fig1){ref-type="fig"}D).

We also observed an age-dependent increase in GFP expression in the brains of flies carrying a reporter gene in which *GFP* expression was under the control of the *attacinA* promoter ([@bib51]) (*Attacin-GFP*; [Figure 2](#fig2){ref-type="fig"}A). In addition, measurements by qPCR revealed an increase in AMP expression in brains of 30-day-old flies compared with their 5-day-old counterparts ([Figure 2](#fig2){ref-type="fig"}B). The results from these experiments indicated that the age-dependent increase in IMD-related AMP gene expression was concerning the brain itself and not just the surrounding tissues.

This age-dependent shift in IMD-related AMP transcription was the result of a specific pattern: a combined decrease in some negative *intracellular* regulators and an increase in *extracellular* negative regulators with a sum total culminating in an increase in *rel* mRNA levels and a rise in AMPs controlled by Rel. Furthermore, the age-dependent increase of AMPs was accompanied by an increase in brain neurodegeneration (see [Figure 2](#fig2){ref-type="fig"}C for sections, [Figure 2](#fig2){ref-type="fig"}D for index, and [Table S1](#mmc2){ref-type="supplementary-material"} for statistics) and locomotion defects (see [Figure 2](#fig2){ref-type="fig"}E and [Table S2](#mmc3){ref-type="supplementary-material"} for statistics) in 50-day-old flies. Taken together, the data above indicated a phenotype where an age-related increase in IMD/NF-κB-driven immunity was combined with a neurological decline. Whether this was a cause-and-effect relationship was our next question.

Loss of NF-κB Intracellular Negative Regulation Predisposes to Early Neurodegeneration and Short Lifespan {#sec2.2}
---------------------------------------------------------------------------------------------------------

We reasoned that one way to explore this question would be to manipulate IMD/NF-κB signaling and measure any changes in the age-dependent neurological state of our flies. The causative relationship between increased IMD/NF-κB signaling levels and age-dependent neurological deterioration was identified previously for loss of Dnr1 ([@bib9]). Therefore, we asked whether disabling other negative regulators and, thus, increasing IMD/NF-κB signaling levels could predispose flies to early onset of neurological decline, brain neurodegeneration, and, finally, reduced lifespan. Brain sections of 5- and 20- or 30-day-old loss-of-function mutants of the intracellular negative regulators (regardless whether their age-dependent expression declined or stayed the same) *posh*, *cyld*, and *caspar* (with their *w*^*1118*^ genetic background as a control) and *tg*, *trbd*, *pirk*, and *drybp* (with their *yw* genetic background as a control) as well as of the extracellular negative regulator *pgrp-lb* (with its *w*^*1118*^ genetic background as a control) were examined at both 25°C (see [Figures 3](#fig3){ref-type="fig"}A and 3B for brain sections and [Figures 3](#fig3){ref-type="fig"}C and 3D and [Table S1](#mmc2){ref-type="supplementary-material"} for index) and 29°C (accelerated aging; see [Figures S2](#mmc1){ref-type="supplementary-material"}A, S2B, and S2E for brain sections, [Figures S2](#mmc1){ref-type="supplementary-material"}C, S2D, and S2F for index, and [Table S1](#mmc2){ref-type="supplementary-material"} for statistical analysis). Early studies examining *Drosophila* lifespan at different temperatures have established a positive relationship between mortality and increase in temperature, therefore suggesting that flies are living and aging faster at 29°C than at 25°C ([@bib3], [@bib36]). At both temperatures, our results revealed a statistically significant increase in the neurodegeneration index for three mutants in intracellular regulators of the IMD pathway; namely, *tg*, *trbd*, and *pirk*. In addition, plotting the neurodegeneration index against Imd transcriptional output (measured by gene expression levels of the AMP *diptericin*) indicated that the *dipt* levels in these three mutants correlated with the highest index ([Figure 3](#fig3){ref-type="fig"}E).

Of note, we found that the neurodegeneration index for conventionally reared mutants of PGRP-LB was comparable with the wild-type. This indicated that, despite the reduction in lifespan reported in the literature ([@bib41]), neurodegeneration was not the cause of early death in this mutant. Moreover, in contrast to *trbd* and *tg* (see below), under germ-free conditions, the lifespan of flies lacking PGRP-LB was restored to normal ([@bib41] and data not shown). This result confirmed previous studies that indicated that the reduction in lifespan in PGRP-LB mutants was due to commensal dysbiosis ([@bib41]).

Along with the age-dependent neurodegeneration in *tg*, *trbd*, and *pirk*, these mutants showed a statistically significant increase in AMP gene expression in heads ([Figure 4](#fig4){ref-type="fig"}A), dissected brains ([Figure 4](#fig4){ref-type="fig"}B), and the rest of the body ([Figure S3](#mmc1){ref-type="supplementary-material"}A) compared with the control. They were therefore exposed to "increased immune signaling from a young age" (predisposition) and were studied further. *Tg*, *trbd*, and *pirk* mutant flies exhibited an early reduction in locomotor activity (see [Figure 4](#fig4){ref-type="fig"}C and [Table S2](#mmc3){ref-type="supplementary-material"} for statistics) and showed a 24.2%, 37.1%, and 9.1% reduction in maximum lifespan, respectively, compared with wild-type controls (see [Figure 4](#fig4){ref-type="fig"}D and [Table S3](#mmc4){ref-type="supplementary-material"} for statistics). In the case of *trbd* and *tg*, lifespan patterns were not influenced by the absence of bacterial populations because they exhibited a statistically non-distinguishable reduction in lifespan under germ-free conditions ([Figure 4](#fig4){ref-type="fig"}D; [Table S3](#mmc4){ref-type="supplementary-material"}). However, the reduction in lifespan of *pirk* mutants was rescued in germ-free flies ([Figure 4](#fig4){ref-type="fig"}D; [Table S3](#mmc4){ref-type="supplementary-material"}), as has been reported elsewhere ([@bib41]). This result was in accordance with the published observation that *pirk* expression was regulated by the presence of the gut microflora ([@bib30]) and underscored the differences between microbe-independent and microbe-dependent intracellular negative regulation of the IMD pathway (see [Discussion](#sec3){ref-type="sec"}).

In contrast to *pirk*, *trbd*, and *tg*, negative regulator mutants that did not show age-dependent neurodegeneration, such as *drybp* ([Figure 3](#fig3){ref-type="fig"}A) and *caspar* ([Figure 3](#fig3){ref-type="fig"}B), had levels of AMPs in their brains similar to controls ([Figure S3](#mmc1){ref-type="supplementary-material"}B) and a lifespan that was not reduced compared with controls (the lifespan for *caspar* was actually increased; see [Figure S3](#mmc1){ref-type="supplementary-material"}C and [Table S3](#mmc4){ref-type="supplementary-material"} for statistics). These results indicated that loss of different intracellular negative regulators had different effects on brain-specific AMP expression and, as a consequence, different effects on brain tissue, locomotion, and, ultimately, lifespan. This result also suggested possible tissue specificity (see [Discussion](#sec3){ref-type="sec"}). These differences notwithstanding, our results indicated that an increase in AMP gene expression did correlate with an increase in neurological decline and reduced lifespan. Indeed, [@bib9] have shown that overexpression of single AMPs increased neurodegeneration). We explored further the underlying neurological and lifespan phenotype and found that individual overexpression of *drosocin*, *attacinC*, or *cecropinA1* in neurons resulted in reduced lifespan and age-dependent climbing ability ([Figures S3](#mmc1){ref-type="supplementary-material"}D and S3E, respectively). Similarly, overexpression of *drosocin*, *attacinC*, or *cecropinA1* in glia resulted in reduced lifespan and age-dependent climbing ability ([Figures S3](#mmc1){ref-type="supplementary-material"}F and S3G, respectively).

Silencing NF-κB in the Brain of Predisposed Flies Restores Lifespan and Suppresses Neurodegeneration {#sec2.3}
----------------------------------------------------------------------------------------------------

In *trbd* mutants, the median lifespan (LT~50~) was 29 days ([Figure 5](#fig5){ref-type="fig"}A; statistics in [Table S3](#mmc4){ref-type="supplementary-material"}; see also [@bib18]). This phenotype was suppressed when *rel* was silenced in neurons (*w*^*1118*^*; elav-GAL4/UAS-Rel*^*RNAi*^*; trbd*, LT~50~ = 42) and even more when *rel* was suppressed in glia (*w*^*1118*^*; repo-GAL4/UAS-Rel*^*RNAi*^*; trbd*), with an LT~50~ of 48 days that was in line with the LT~50~ (52 days) of its genetic background ([Figure 6](#fig6){ref-type="fig"}A; [Table S3](#mmc4){ref-type="supplementary-material"}). Mating rates were statistically indistinguishable in all different RNAi interventions compared with controls and *trbd* mutants ([Table S6](#mmc7){ref-type="supplementary-material"}). Finally, the lifespan of *trbd* flies with only either of the GAL4 drivers or just the *UAS-Rel*^*RNAi*^ transgene was statistically indistinguishable from *trbd* alone (data not shown).

Compared with 5-day-old and 30-day-old controls, *rel-*silenced flies exhibited reduced AMPs in heads ([Figure 5](#fig5){ref-type="fig"}B). Neurodegeneration was reduced, and locomotor activity increased when *rel* was silenced in glia (see [Figure 5](#fig5){ref-type="fig"}C for brain sections, [Figure 5](#fig5){ref-type="fig"}D and [Table S1](#mmc2){ref-type="supplementary-material"} for index, and [Figure S4](#mmc1){ref-type="supplementary-material"}A and [Table S2](#mmc3){ref-type="supplementary-material"} for locomotor assays), but not when it was silenced in neurons (see [Figure S4](#mmc1){ref-type="supplementary-material"}B for brain sections, [Figure S4](#mmc1){ref-type="supplementary-material"}C and [Table S1](#mmc2){ref-type="supplementary-material"} for index, and [Figure S4](#mmc1){ref-type="supplementary-material"}D and [Table S2](#mmc3){ref-type="supplementary-material"} for locomotor assays). This result underlined the role of glia in the immunity-to-brain axis whereby suppressing immunity in glia rescued both neurodegeneration and locomotion and, thus, restored lifespan to wild-type levels. The data also supported the notion that predisposition to early neurodegeneration was determined by IMD/NF-κB pathway levels.

Suppressing NF-κB Immune Signaling in Healthy Flies Extends Lifespan {#sec2.4}
--------------------------------------------------------------------

If increased levels of IMD/NF-κB signaling led to the reduction of lifespan with early onset of age-related neurological decline, we wanted to test whether a decrease in normal IMD signaling levels in healthy flies from the beginning of their life could have the opposite effect. To this end, we initially assayed the effects on lifespan of two IMD-null mutants (*yw; dredd*^*B118*^ and *w*^*1118*^*; rel*^*E20*^), one hypomorphic mutant (*w*^*1118*^*; dredd*^*EP1412*^), and their genetic backgrounds to which the mutant strains were backcrossed for ten generations as recommended ([@bib24]). *Dredd*- or *rel*-null flies had a statistically significant reduction in lifespan compared with their genetic backgrounds ([Figure 6](#fig6){ref-type="fig"}A; [Table S3](#mmc4){ref-type="supplementary-material"}). However, the hypomorphic *w*^*1118*^*; dredd*^*EP1412*^, although it showed the same significant reduction in LT~50~ as the null IMD pathway mutants compared with controls, also displayed a statistically significant increase in less than 90% (LT~90~) and maximum lifespan ([Figure 6](#fig6){ref-type="fig"}A; [Table S3](#mmc4){ref-type="supplementary-material"}). However, no difference was observed in neurodegeneration in both brain sections ([Figure 6](#fig6){ref-type="fig"}B; [Table S1](#mmc2){ref-type="supplementary-material"}) and index ([Figure 6](#fig6){ref-type="fig"}C; [Table S4](#mmc5){ref-type="supplementary-material"}).

Nevertheless, this result suggested the possibility that a lower (but not null) IMD pathway activity could increase the maximum lifespan in some flies by reducing the cost of the age-dependent increase in levels of immune activity. To test this idea, we used the galactose responsive transcription factor 4/upstream activation sequence (GAL4/UAS) system to suppress *rel* via RNAi in either neurons (*elav-*GAL4) or glia (*repo-*GAL4) or the intestine (*np1-*GAL4). The latter GAL4 driver was used because the gut has been suggested to be the tissue where upregulation of *rel* causes age-related commensal dysbiosis ([@bib23]). Previous studies have demonstrated that induction of the RNAi mechanism itself in the nervous system or gut does not influence adult lifespan ([@bib2]). In addition, the mating rates were statistically indistinguishable in all different RNAi interventions compared with controls ([Table S6](#mmc7){ref-type="supplementary-material"}).

Our results indicated a significant extension of lifespan when *rel* was suppressed in either neurons or glia ([Figure 6](#fig6){ref-type="fig"}D). In our hands (see [Experimental Procedures](#sec4){ref-type="sec"}), the genetic background *w*^*1118*^ had an LT~50~ of 52 days and an LT~90~ of 62 days, with a maximum lifespan of 65 days (see [Figure 6](#fig6){ref-type="fig"}D for a graph and [Table S3](#mmc4){ref-type="supplementary-material"} for statistics). In comparison, the *w*^*1118*^*; elav-GAL4; UAS-Rel*^*RNAi*^ LT~50~ was 67 days (an increase of 29%) and an LT~90~ of 79 days with a maximum lifespan of 88 days (35% increase). For *w*^*1118*^*; repo-GAL4; UAS-Rel*^*RNAi*^, the LT~50~ was 84 days (an increase of 61%), the LT~90~ was 95 days, and the maximum lifespan was 106 days (an increase of 63%; [Figure 6](#fig6){ref-type="fig"}D and [Table S3](#mmc4){ref-type="supplementary-material"}). We also observed a comparatively modest (but statistically significant) increase in lifespan in *w*^*1118*^; *np1-GAL4; UAS-Rel*^*RNAi*^, as recently documented ([@bib23]). In *w*^*1118*^; *np1-GAL4; UAS-Rel*^*RNAi*^ flies, the LT~50~ was 61 days and the maximum lifespan 70 days. However, *w*^*1118*^; *np1-GAL4* alone had a slightly increased LT~50~ compared with *w*^*1118*^, which was not the case for *w*^*1118*^; *elav-GAL4* or *w*^*1118*^; *repo-GAL4* ([Figure 6](#fig6){ref-type="fig"}D; [Table S3](#mmc4){ref-type="supplementary-material"}). Interestingly, flies with glia- or neuron-specific suppression of immunity signaling did not show a reduction in brain neurodegeneration levels compared with controls (see [Figure S5](#mmc1){ref-type="supplementary-material"}A for brain sections, [Figure S5](#mmc1){ref-type="supplementary-material"}B for glia index, and [Figure S5](#mmc1){ref-type="supplementary-material"}C for neuron index) even though AMPs in the heads were significantly reduced as expected ([Figure S5](#mmc1){ref-type="supplementary-material"}D). This indicated that a reduction in the basal level of neurodegeneration was not the reason for lifespan extension. Nevertheless, glia-specific (but not neuron-specific) suppression resulted in increased locomotion in older flies ([Figure 6](#fig6){ref-type="fig"}E). This indicated that the lifespan extension in *w*^*1118*^*; repo-GAL4; UAS-Rel*^*RNAi*^ flies was not just an extension of the moribund phase but corresponded to more activity in old age. An extension of lifespan statistically comparable with *w*^*1118*^*; repo-GAL4; UAS-Rel*^*RNAi*^ flies was also observed in *w*^*1118*^*; repo-GAL4; UAS-dredd*^*RNAi*^ flies and *w*^*1118*^*; repo-GAL4; UAS-imd*^*RNAi*^ flies, two IMD pathway components upstream of Relish (see [Figure 6](#fig6){ref-type="fig"}F and [Table S3](#mmc4){ref-type="supplementary-material"} for statistics). To verify whether mating had an effect, we reproduced the same result in mated females only (see [Figure S5](#mmc1){ref-type="supplementary-material"}E and [Table S6](#mmc7){ref-type="supplementary-material"} for statistics). Crucially, this extension was also correlated with a greater locomotor activity in later life (see [Figure 6](#fig6){ref-type="fig"}G and [Table S5](#mmc6){ref-type="supplementary-material"} for statistics). These results reinforced the notion that IMD/NF-κB signaling in the brain was linked to life expectancy in flies.

An Immune-Neuroendocrine Axis Mediates Lifespan Extension in Flies {#sec2.5}
------------------------------------------------------------------

The observed increase in physical performance in old age in flies with suppressed Imd signaling in glial cells was accompanied by doubling of the transcriptional levels of the adipokinetic hormone (Akh) hormone ([Figure 7](#fig7){ref-type="fig"}A). In contrast, this was not the case for mutants of negative regulators (*trbd*, *tg*, and *pirk*), where the pathway was constitutively active ([Figure S6](#mmc1){ref-type="supplementary-material"}A).

Akh, which has glucagon-like functions, has been shown to increase the levels of blood glucose ([@bib26]) as well as to extend lifespan and modulate climbing activity in *Drosophila* ([@bib52]). It has also been shown to sustain flight in locusts, tobacco hornworm moths, and certain beetles (reviewed in [@bib20]). In addition, its homolog in mice decelerates aging ([@bib53]). Consistent with the above, injections of a locust Akh in 30-day-old (see [Figure 7](#fig7){ref-type="fig"}B for a 5-cm climb in 10 s) and 50-day-old wild-type *Drosophila* increased locomotion (see [Figure 7](#fig7){ref-type="fig"}C for a 5-cm climb in 10 s and [Figure 7](#fig7){ref-type="fig"}D for a 2.5-cm climb in 10 s).

To corroborate the role of AKH as the effector of lifespan extension, we measured metabolic markers that have been associated with AKH signaling in *Drosophila* ([@bib29], [@bib6]). 30-day-old *w*^*1118*^*; repo-GAL4; UAS-Rel*^*RNAi*^ flies showed a statistically significant increase in glucose levels (free glucose levels in whole flies; [Figure 7](#fig7){ref-type="fig"}B) as well as in circulating trehalose (representing glucose dimers; [Figure 7](#fig7){ref-type="fig"}C). Of note is that levels of glycogen, which represented stored glucose, were unchanged relative to controls ([Figure S6](#mmc1){ref-type="supplementary-material"}E). Consistent with the action of AKH signaling on mobilization of lipid stores, triglycerides (TAGs) as well as total dry mass (but not total weight) were increased in long-lived flies ([Figure 7](#fig7){ref-type="fig"}E). In contrast, total protein levels were indistinguishable from *w*^*1118*^ controls and *w*^*1118*^*; repo-GAL4* flies ([Figure S6](#mmc1){ref-type="supplementary-material"}F). Finally, the metabolic changes observed were not due to calorie restriction because the feeding rates between long-lived and control flies were statistically indistinguishable ([Figure 7](#fig7){ref-type="fig"}F). Taken together, the above results indicated that, during healthy aging, suppression of NF-κB activity delayed neurological decline through a mechanism involving an immune-endocrine axis that seems to be evolutionary conserved in mice ([@bib53]).

Discussion {#sec3}
==========

Loss of IMD Homeostasis Predispose to Age-Dependent Neurodegeneration {#sec3.1}
---------------------------------------------------------------------

We have shown that, in *Drosophila*, an age-related pattern of increased NF-κB-controlled immune activity is caused by a parallel reduction in intracellular negative regulation. As seen in germ-free flies, this age-dependent rise in immune levels was observed downstream of IMD but not TOLL. Moreover, axenic conditions revealed that this increase was, to a large extent, due to the microbial environment. However, the trend of this increase (albeit at a reduced scale) remained in germ-free flies, indicating a mechanism independent of the microbiota.

This phenomenon was also accompanied by neurological and locomotor decline, but it was unclear whether this was a consequence of increased immune activation. If this were the case, we hypothesized that loss-of-function mutations in intracellular negative regulators of IMD would predispose flies to high AMP levels and, thus, to immune-dependent early neurodegeneration. Indeed, overexpression of AMPs with *repo-* or *elav-GAL4* can cause lesions in the brain at 25 days of age ([@bib9]). Moreover, overexpression of the AMPs *drosocin*, *attacinC*, and *cecropinA1* in neurons or glia was accompanied by a reduction in lifespan and early appearance of locomotor defects in comparison with controls. Taken together, these results indicate a causative relationship between high levels of AMPs and neurodegeneration. Indeed, plotting the neurodegeneration index against the levels of the AMP gene *diptericin* in various mutant and control genetic backgrounds showed that increased neurodegeneration correlated with increased *dipt* levels ([Figure 3](#fig3){ref-type="fig"}E).

Nevertheless, [@bib42] have suggested that it shows correlation, not causation, because *imd* alleles still show neurodegeneration. This view correlates with our results showing that both loss of function of IMD signaling components as well as silencing by RNAi in the brain of these same components did not reduce basal neurodegeneration. Therefore, the basal levels of neurodegeneration in healthy aging are primarily NF-κB-independent. Alternatively, the histological method we have used may not be sensitive enough to detect any potential small changes. Nevertheless, downregulation of NF-κB extends the active lifespan despite levels of neurodegeneration remaining constant. This shows that, when IMD is under normal regulatory conditions, longevity is determined by control of metabolism rather than neurodegeneration (see below). Conversely, when IMD control is lost, and AMPs increase to toxic levels, causing early neurodegeneration ([@bib9]; this study), NF-κB activity is the dominant lifespan determinant over and above any metabolic process.

Loss of four intracellular IMD negative regulators, Trbd, Pirk, Tg (this study), and Dnr-1 ([@bib9]), resulted in early neurodegeneration in combination with a reduction in lifespan. Nevertheless, the IMD pathway is negatively regulated at most steps. Therefore, the question arises of why loss of these particular four intracellular negative regulators produced age-dependent neurodegeneration.

Our view is that the data underscore the context and/or tissue-dependent nature of IMD signaling and the difference between intracellular control exerted when interacting with the gut microbiota and/or upon infection (*dusp36*, *pgrp-le*, *pirk*, and *drybp*) (see [@bib48], [@bib7], [@bib30]; and [@bib4]; respectively) versus infection-independent homeostatic control (*dnr-1*, *trbd*, and *tg*) (see [@bib9], [@bib18]; and [@bib45]; respectively). For example, Pirk is the upstream-most flora-dependent intracellular negative regulator that is a target of the pathway, and, therefore, its loss will result in the absence of an important negative feedback loop ([@bib30]). Nevertheless, this feedback loop is not important for lifespan in the absence of the gut microflora ([@bib41]). In contrast, flies reared under germ-free conditions reveal that intracellular regulators such as Trbd are important for IMD pathway homeostasis independent of the microbial environment ([@bib18]). A non-canonical or tissue-specific IMD pathway may also be at play in the brain, as has been suggested for the fly retina ([@bib10]) or in an ataxia telangiectasia model ([@bib42]).

Loss of negative regulation in IMD signaling in the brain led to tissue disruption and early neurodegeneration. This phenotype was accompanied by a severe reduction in lifespan and locomotor defects. However, when Relish was silenced in glia of *trbd* mutants, brain lesions, lifespan, and locomotion were restored and comparable with healthy control flies. This showed that all effects were due to the derepression of NF-kB signaling.

Our results indicate that reduction of lifespan in *tg* and *trbd* is microbe-independent. We suggest that the main reason for this lifespan reduction is the microbiota-independent part of the early increase in AMPs in those mutants. Interestingly however, the lifespan reduction in *pirk* mutant flies was rescued under germ-free conditions. Because *pirk* mutants display early neurodegeneration, this raises the possibility of a gut-brain axis that may include a microflora-dependent component, which, in turn, influences brain neurodegeneration. Indeed, it has been shown previously that, as flies age, their gut becomes leaky, resulting in aging decline with a strong microbiota-driven component ([@bib43]). More work is needed to understand this interaction.

Finally, our work indicates that the age-dependent regulation of the Imd pathway is at a state of allostasis (when homeostasis is achieved through change). Taken at specific time points, signaling output is defined by the microbial environment, and, in the absence of infection, it is tightly regulated to a basal level. However, this basal level increases in an age-dependent manner. By culturing germ-free *Drosophila*, we were able to pinpoint the component of this signaling that is microbe-independent and intrinsic to the host.

Suppression of IMD Extends Lifespan {#sec3.2}
-----------------------------------

Lowering the levels of IMD signaling by RNAi in glia of healthy flies extended the lifespan by more than 60% in LT~50~ and increased physical activity in old age. Our results agree with a previous observation that pharmacological inhibition of NF-κB modestly extends the *Drosophila* lifespan (20% of LT~50~; [@bib38]). However, we go further to indicate mechanism and tissue specificity. Lifespan extension was not achieved by lower levels of neurodegeneration but by an increase in AKH signaling. This indicated that the basal level of neurodegeneration in healthy flies was independent of IMD/NF-κB.

Extension of lifespan was accompanied by an altered metabolic profile, including statistically significant increases in free glucose, trehalose, and TAGs, whereas there was no significant difference in glycogen and protein levels. This suggested a shift toward catabolism, leading to the immediate use of carbohydrates and fats (as opposed to storing them) to fulfill the energetic requirements of long-lived flies. Increases in glucose, trehalose, and TAGs were consistent with the upregulation of *akh* expression and confirmed IMD signaling as a potent modulator of lifespan upstream of AKH.

More work is needed to identify the NF-κB targets in glia that enable AKH activation and establishment of this immune-neuroendocrine axis. We speculate that this is not a direct transcriptional relationship because *akh cis*-regulatory elements do not have NF-κB binding sites (unpublished data). One possible connection however, could be through Mef2 ([@bib12]). Mef2 is an in vivo immune-metabolic switch controlled by NF-κB that can alternate between immune and metabolic gene expression. Upon infection, NF-κB activity recruits Mef2 as an immune regulator. A tempting hypothesis is that, by lowering NF-κB signaling under homeostatic conditions, Mef2 is freer to increase its involvement in metabolic activity.

Our results point to IMD/NF-κB signaling in the brain as a major determinant of *Drosophila* lifespan. The LT~50~ (84 days) of *w*^*1118*^*; repo-GAL4; UAS-Rel*^*RNAi*^ is a statistically indistinguishable percent extension of LT~50~ compared with *w*^*1118*^*; methuselah* ([@bib32]), lifespan extension by loss of insulin signaling ([@bib11]), or calorie restriction ([@bib34]). Our data put under an evolutionary perspective studies in mice where a similar NF-κB-controlled immune-neuroendocrine integration led to modulation of hormone levels and lifespan extension ([@bib53]). However, our results go further to indicate that NF-κB signaling levels regulate both healthy aging as well as age-related neurodegenerative disease. Given the evolutionary conservation of NF-κB innate immune signaling in flies, mice, and humans, opposing the inflammatory effects of NF-κB may represent a common strategy to increase active lifespan in both the context of healthy aging as well as in cases of predisposition to age-related neurological disease.

Experimental Procedures {#sec4}
=======================

*Drosophila* Stocks and Genetics {#sec4.1}
--------------------------------

Flies were maintained on cornmeal-molasses medium at 25°C unless otherwise stated. For a complete list of the strains used, check the [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}.

Lifespan Studies and Production and Maintenance of Germ-free Flies {#sec4.2}
------------------------------------------------------------------

For lifespan studies, all fly strains were backcrossed for ten generations to their respective genetic background as recommended previously ([@bib24]). When these "lifespan-ready" strains were established, cohorts of 20 flies (10 males and 10 females) were put in vials and monitored for their survival in 12 biological replicates (n = 240/strain). The flies were transferred to fresh food every 2 days. Germ-free flies were produced as described previously ([@bib18]) and checked every 5 days for bacterial contamination by performing PCR analysis on fly homogenates using 16S eubacterial primers (63F//1387R) as well as by culturing the homogenates on LB plates.

Histology and Neurodegeneration Score {#sec4.3}
-------------------------------------

Histological analysis and determination of the neurodegeneration index were done as described previously ([@bib9]). For a detailed description, check the [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}.

Gene Expression in Brains {#sec4.4}
-------------------------

Quantitative real-time PCR was used to measure mRNA expression. 30--40 fly brains were dissected at the indicated time points, and RNA was isolated using TrizolRT (Molecular Research Center) according to the manufacturer's instructions. cDNA was prepared from 0.5 μg total RNA using the iScript cDNA synthesis kit (Bio-Rad). Real-time PCR was carried out using iQ SYBR Green Supermix (Bio-Rad). Primer sequences are presented in the [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}.

Gene Expression in Heads, the Rest of the Body, and Whole Flies {#sec4.5}
---------------------------------------------------------------

Total RNA was extracted from whole flies (6 females), the rest of the body (8 females), and heads (30 females) using the Total RNA Purification Plus kit (Norgen Biotek), and cDNA was prepared from 0.5 μg total RNA using the Maxima First Strand cDNA synthesis kit (Thermo Scientific). Triplicate cDNA samples were amplified with the SensiFASAT SYBR No-ROX kit (Bioline) in a Corbet Rotor-Gene 6000 qPCR machine (QIAGEN) according to the manufacturer's protocols. Primer sequences are presented in the [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}.

Statistical Analysis {#sec4.6}
--------------------

All statistical analyses were performed using GraphPad Prism software (GraphPad). All qPCR data were analyzed using nonparametric unpaired Student's t test corrected for multiple comparisons (Bonferroni correction). Significant differences between the survival data of different genotypes were identified using log rank and Wilcoxon tests (chi-square and p values). The neurodegeneration index and climbing assay data were analyzed using one- or two-way ANOVA with Tukey and Bonferroni post tests, respectively. In all tests, p \< 0.05 was considered significant.
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![Healthy Aging in *Drosophila* Is Characterized by Age-Dependent Upregulation of Immunity\
(A--D) In the heads of 30-day old flies, gene expression of intracellular negative regulators of IMD was reduced, whereas gene expression of extracellular negative regulators was increased (A). This pattern was accompanied by a significant increase in AMP gene expression in the head (B), the rest of the body, and whole flies (C, comparative graph). IMD-dependent (but not TOLL-dependent) AMP gene expression was also increased with age in the heads of 30-day-old germ-free flies (D). Values shown are mean ± SEM.](gr1){#fig1}

![Increase of AMP Levels in the Brain Correlates with Neurological Decline\
(A) Confocal stacks of 5- and 50-day-old (top and bottom panels, respectively) *Attacin-GFP* optic lobes of brains immunostained for GFP (green), the glial marker Repo (red), and the neuronal marker Elav (blue). All three markers are shown in the merged image. An increase in GFP staining is observed in the brains of older flies, where GFP co-localizes with both Repo (asterisks) and Elav (arrowheads). The boxed regions show an enlarged image of the optic lobes. Representative images are shown. n = 19 (5 days old) and n = 12 (50 days old). Scale bars, 50 μm.\
(B--E) Significant age-dependent upregulation of AMPs in brains was also observed by qPCR (B). This increase was accompanied by neurodegeneration (arrowheads) in 50-day-old flies as observed (C) and quantified (D) in midbrain sections. This was coupled to a reduction in locomotor activity in 50-day-old flies (E).\
In all experiments, the fly strain used was *w*^*1118*^. Values shown are mean ± SEM. Asterisks denote statistically significant differences (^∗^p ≤ 0.05, ^∗∗∗^p ≤ 0.001. ns, non-significant.](gr2){#fig2}

![Loss of Intracellular Negative Regulators of NF-κB/Relish Triggers Early Onset of Neurodegeneration\
5- and 30-day-old mutants for intracellular negative regulators of the IMD pathway, aged at 25°C, were examined for age-dependent neurodegeneration by histology and then quantified.\
(A) Midbrain sections of *caspar* mutant flies did not show any differences compared with their genetic background (age-matched w^*1118*^ controls). However, some sections showed an increase in *cyld* and *posh* mutants (data not shown).\
(B) Mutants for the intracellular negative regulators *pirk*, *trbd*, and *tg*, but not *rybp*, showed increased age-dependent neurodegeneration in midbrain sections.\
(C) When quantified, *caspar* mutant flies had a neurodegeneration index indistinguishable to *w*^*1118*^ controls, whereas *posh* and *cyld* had a significant increase in neurodegeneration.\
(D) Quantification of *pirk*, *trbd*, and *tg*, but not *rybp*, revealed a neurodegeneration index that was significantly different from *yw* controls.\
(E) Neurodegeneration index in correlation with Imd pathway output (as measured by *dipt* gene expression). The increase in neurodegeneration correlated with an increase in mRNA levels of *dipt*.\
Values shown are mean ± SEM. Asterisks denote statistically significant differences (^∗^p ≤ 0.05, ^∗∗^p ≤ 0.01, ^∗∗∗^p ≤ 0.001).](gr3){#fig3}

![Loss of Intracellular Negative Regulators of NF-κB/Relish Leads to a Brain-Specific Increase in Expression of AMPs, Locomotor Defects, and Shorter Lifespan\
(A--D) A significant increase in AMP gene expression in comparison with *yw* controls was observed in heads (A) and dissected brains (B) of *pirk*, *trbd*, and *tg* mutants that correlated with a decrease in locomotor activity (C). The shorter lifespan of *pirk*, but not *trbd* or *tg* mutants, was rescued under germ-free (GF) conditions (D). Values shown are mean ± SEM. Asterisks denote statistically significant differences (^∗^p ≤ 0.05, ^∗∗^p ≤ 0.01, ^∗∗∗^p ≤ 0.001).](gr4){#fig4}

![Predisposition to Neurodegeneration Is Suppressed by Reducing NF-κB/Relish in the Brain\
(A and B) In *trbd* mutants, reduction of lifespan (A) and upregulation of AMPs (B) were suppressed by silencing *rel* in neurons (*elav-GAL4*) or glia (*repo-GAL4)*.\
(C and D) Neurodegeneration in brain sections (C) and quantification (D) showed that lifespan extension was accompanied by fully rescued neurodegeneration only when *rel* was silenced in glia (compare with [Figure S4](#mmc1){ref-type="supplementary-material"}B for sections when *rel* was silenced in neurons).\
Values shown are mean ± SEM. Asterisks denote statistically significant differences (^∗∗^p ≤ 0.01, ^∗∗∗^p ≤ 0.001).](gr5){#fig5}

![Glial Suppression of IMD/NF-κB Signaling in Healthy Flies Extends Active Lifespan\
(A--C) The maximum lifespan of a hypomorphic allele of *Dredd* (*Dredd*^*EP1214*^) showed a modest extension compared with *w*^*1118*^ controls. Nevertheless, midbrain sections (B) and quantification (C) of *yw; dredd*^*B118*^*, w*^*1118*^*; rel*^*E20*^-null mutants and a *w*^*1118*^*; dredd*^*EP1412*^ hypomorphic mutant showed no difference in neurodegeneration compared with controls.\
(D--G) RNAi-dependent silencing of *rel* in glia resulted in a very substantial extension of lifespan (D) and amelioration of the age-dependent decline in locomotor activity (E). Similarly, glial knockdown of *Dredd* and *Imd* resulted in lifespan extension (F) and amelioration of the age-dependent decline in locomotor activity (G).\
Values shown are mean ± SEM. Asterisks denote statistically significant differences (^∗^p ≤ 0.05, ^∗∗^p ≤ 0.01, ^∗∗∗∗^p ≤ 0.0001).](gr6){#fig6}

![Lifespan Extension following Glial Suppression of IMD/NF-κB Signaling Is Accompanied by Metabolic Changes\
(A) The RNAi-dependent silencing of *rel*, *dredd*, and *imd* resulted in an increase in *Akh* transcription.\
(B--F) Increased AKH signaling triggered rises in (B) glucose, (C) trehalose, and (D) TAG levels that built up an increase in dry mass (E). Nevertheless, feeding rates were comparable with controls when *rel* was silenced in glia (F).\
Values shown are mean ± SEM.](gr7){#fig7}
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